On December 4^th, Intesa Sanpaolo in co-operation with Assobiotec organized an event to present the 2nd Report on the Bioeconomy in Europe.

The report, compiled by Intesa Sanpaolo Think Tank, shows once again the growing value of the bioeconomy in Europe.  As a matter of fact, this sector is worth more than €1.2 trillion and employs nearly 7.5 million people in the five major EU countries, Italy, Spain, France, Germany and the UK.

GFBiochemicals joined other leaders of Italy’s biobased industries to highlight its key developments and challenges, with a presentation during the session about ‘Industrial biotechnologies as an engine for the bioeconomy’.

Daniela Ribezzo, our Global Business Development Manager, talked about the impact of levulinic acid and its derivatives on the growth of the bioeconomy not only in Europe but also in the rest of the world.  She focused on highlighting that main drivers for the use of levulinic acid and its derivatives, as substitutes for oil-based products, are performance and functionality.